Conmed (CNMD) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Brazil’s Lula wins historic fourth term, Flavio Bolsonaro refuses to concede
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- Borr Drilling rig sinks off Gabon, one person dead and four missing
- Oil settles lower on peace hopes, Saudi attacks limit losses
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
CONMED Corporation Announces Fourth Quarter and Full-Year 2019 Financial Results
January 29, 2020 4:01 PM ESTUTICA, N.Y.--(BUSINESS WIRE)-- CONMED Corporation (Nasdaq: CNMD) today announced financial results for the fourth quarter and full year ended December 31, 2019.
Fourth Quarter 2019 Highlights
Sales of $264.9 million increased 9.2% year over year as reported and 9.3% in constant currency. Acquisitions contributed approximately 670 basis points of growth. Domestic revenue increased 13.8% year over year. International revenue increased 4.4% as reported and 4.5% in constant currency. Operating margin decreased 20 basis points on a GAAP basis and increased 110 basis points on an adjusted basis(1), compared to the fourth... More


